SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-019089
Filing Date
2022-05-10
Accepted
2022-05-10 08:25:40
Documents
57
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cogt-10q_20220331.htm   iXBRL 10-Q 1347237
2 EX-10.1 cogt-ex101_49.htm EX-10.1 73163
3 EX-31.1 cogt-ex311_6.htm EX-31.1 9991
4 EX-31.2 cogt-ex312_8.htm EX-31.2 9964
5 EX-32.1 cogt-ex321_9.htm EX-32.1 5970
6 EX-32.2 cogt-ex322_7.htm EX-32.2 5935
7 GRAPHIC gdr4hybz3mg3000001.jpg GRAPHIC 59925
  Complete submission text file 0001564590-22-019089.txt   5250104

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA cogt-20220331.xsd EX-101.SCH 42903
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cogt-20220331_cal.xml EX-101.CAL 39559
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cogt-20220331_def.xml EX-101.DEF 147583
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE cogt-20220331_lab.xml EX-101.LAB 328990
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cogt-20220331_pre.xml EX-101.PRE 245681
51 EXTRACTED XBRL INSTANCE DOCUMENT cogt-10q_20220331_htm.xml XML 701592
Mailing Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140
Business Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140 617-945-5576
Cogent Biosciences, Inc. (Filer) CIK: 0001622229 (see all company filings)

IRS No.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38443 | Film No.: 22907499
SIC: 2834 Pharmaceutical Preparations